Former Intel chairman Andrew Grove is assailing the U.S. medical establishment again, this time with a jeremiad in which he blames the drug industry for not moving at the speed of Moore’s law. Of course, there’s plenty in the drug industry to criticize, but over at VentureBeat Life Sciences, we look at why Grove’s specific analysis is way off base, and how he also seems to overlook a major but little-noticed problem in the system — one that he’s in an excellent position to do something about. Check it out here.
VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn More